Kapil D. Sethi
Georgia Regents University
198 Papers
1.1K Citations
Kapil D. Sethi is an academic researcher from Georgia Regents University. The author has contributed to research in topics: Medicine & Parkinson's disease. The author has an hindex of 51, co-authored 182 publications.
Chat about Author
Papers
Response to ropinirole in restless legs syndrome is independent of baseline serum ferritin
TL;DR: A post hoc analysis of combined data from two pivotal RLS clinical trials revealed equal benefits of ropinirole over placebo in patients with serum ferritin above or below 50 μg/l.
8
Benign paroxysmal positional vertigo in Parkinson’s disease
Shachie V. Aranke,Kapil D. Sethi +1 more
TL;DR: Three PD patients with dizziness due to benign paroxysmal positional vertigo (BPPV) are presented with blank facies, moderate to severe neck rigidity, as well as appendicular rigidity.
8
Gaze-evoked involuntary movement
TL;DR: Two patients in whom eccentric gaze evoked facial twitching and arm movement are reported in whom Electroencephalograms remained unchanged during these movements.
8
Utility of urinary biomarkers in primary haematuria: Systematic review and meta‐analysis
N. Soputro,Dylan Neil Gracias,Brendan Hermenigildo Dias,Tatenda Nzenza,Helen E O'Connell,Kapil D. Sethi +5 more
TL;DR: To evaluate the diagnostic performance of FDA‐approved urinary biomarkers in the evaluation of primary haematuria for investigation of bladder cancer, a large number of biomarkers were found to be positive for bladder cancer.
8
The role of radiotracer imaging in Parkinson disease.
Bernard Ravina,David Eidelberg,J. Eric Ahlskog,R. L. Albin,David J. Brooks,Maren Carbon,Vijay Dhawan,Andrew Feigin,Stanley Fahn,M. Guttman,Katrina Gwinn-Hardy,Henry F. McFarland,R. B. Innis,R. G. Katz,K. Kieburtz,Stephen J. Kish,N. Lange,J. W. Langston,K. Marek,L. Morin,Claudia S. Moy,Declan G. Murphy,W. H. Oertel,G. Oliver,Y. Palesch,William J. Powers,John Seibyl,Kapil D. Sethi,Clifford W. Shults,P. Sheehy,A. J. Stoessl,Robert G. Holloway +31 more
TL;DR: No radiotracers fulfill these criteria, and current evidence does not support the use of imaging as a diagnostic tool in clinical practice or as a surrogate endpoint in clinical trials.
8